SCHEMBL14923474

SCHEMBL14923474

CC(C)(C)OC(=O)N[C@H](CN)c1cccnc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.46
NAMPT P43490 2/20 0.44
CTSS P25774 1/20 0.43
CTSK P43235 1/20 0.43
CYP3A4 P08684 6/20 0.42
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
PKM P14618 1/20 0.42
HPGD P15428 1/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
XBP1 P17861 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HSD17B10 Q99714 1/20 0.42
RPS6KA5 O75582 2/20 0.41
AKT1 P31749 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14931099 0.88 RAB9A (0.47) RAB9ANAMPTCTSSCTSKCYP3A4
SCHEMBL4603000 0.88 RAB9A (0.47) RAB9ANAMPTCTSSCTSKCYP3A4
SCHEMBL739456 0.86 SUCNR1 (0.49) RAB9ANAMPTCTSSCTSKCYP3A4
SCHEMBL14923471 0.86 RAB9A (0.45) RAB9ANAMPTCTSSCTSKCYP3A4
SCHEMBL739452 0.86 SUCNR1 (0.49) RAB9ANAMPTCTSSCTSKCYP3A4
SCHEMBL6608864 0.85 RAB9A (0.49) RAB9ANAMPTCTSSCTSKCYP3A4
SCHEMBL18511285 0.85 KCNA5 (0.48) RAB9ANAMPTCTSSCTSKCYP3A4
SCHEMBL3371141 0.85 RAB9A (0.47) RAB9ANAMPTCTSSCTSKCYP3A4
SCHEMBL9717939 0.84 RAB9A (0.45) RAB9ANAMPTCTSSCTSKCYP3A4
SCHEMBL3755737 0.84 CTSK (0.54) CTSSCTSKALDH1A1MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102958918-B Novel tobacco amide derivatives or its salt FUJIFILM CORP. (JP) 2015-12-09 CN disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed
EP-2589592-A1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM Corporation (JP) 2013-05-08 EP disclosed
CN-102958918-A Novel nicotinamide derivatives or salts thereof FUJIFILM CORP 2013-03-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK RAB9A 2445/4885NAMPT 12/4885CTSS 3435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.